Prof Bruno Pozzetto, MD, PhD is an expert in Virology at Centre Hospitalier Universitaire de Saint-Etienne (France). Bruno Pozzetto has authored 469 publications, the most recent in 2026, and is an investigator in 9 clinical trials. SLR score: 1,251 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Bruno Pozzetto, MD, PhD Centre Hospitalier Universitaire de Saint-Etienne France
1 251 ScienceLeadR Reputation 1251
Network Map

Virology

Subspecialties: Infectiology - Dentistry - Immunology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 1989 - 2026

Source: PubMed

Centre Hospitalier Universitaire de Saint-Etienne

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 469

Citations

Citations: 12 176 1st author: 33 Last author: 84 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Fatal encephalitis caused by Shamonda virus Europe 1 (SHAV-EU1) in a patient with a severely weakened immune system, France, 2026.
PMID 42921678 — microscopy, electron, scanning transmission, viruses, immune system, communicable diseases, encephalitis
Euro Surveill20261
Interplay Between Oral Microbiota and Mouth Health in People Living With HIV Under Antiretroviral Therapy With or Without Periodontitis.
PMID 41969371 — dysbiosis, hiv, therapeutics, periodontitis, mouth, microbiota, plasma, oral microbiome
Int J Dent20260
How multidisciplinary teams matter in public health expertise: A case study on the 2023 French infectious disease prioritization exercise.
PMID 41712964 — exercise, pediatricians, multiple chronic conditions, public health, physicians, communicable diseases
Public Health20260
Safety, tolerability, and pharmacokinetics of an annual tenofovir alafenamide silicone subdermal implant in South African women: a two-part, randomised, placebo-controlled, double-blind, first-in-human, phase 1 trial.
PMID 40587987 — cells, tenofovir, safety, incidence, aged, drug-related side effects and adverse reactions, silicones, hiv infections, pharmacokinetics
Lancet HIV20252
Diversity of immunization strongly impacts SARS-CoV-2 antibody function surrogates.
PMID 40730842 — sars-cov-2, immunization, serology, immunity, severe acute respiratory syndrome-related coronavirus
NPJ Vaccines20250

Clinical Studies 9

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 8
Phase 4 1

By status:

Completed 8
Active not recruiting 1

By type:

Interventional 6
Observational 3

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 1
multicentric5to9 0
multicentricup10 1

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map